{"recordsFiltered":49605,"recordsTotal":49605,"next":null,"previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=title&start=49200","results":[{"registry_id":"NCT07526753","publication_url":"https://clinicaltrials.gov/study/NCT07526753","title":"Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries","has_exemption":false,"start_date":"2026-03-15","completion_date":"2035-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06931301","publication_url":"https://clinicaltrials.gov/study/NCT06931301","title":"Effect of Hyperbaric Oxygen Therapy on Osteonecrosis of the Femoral Head When Combined With 3D Navigated Core Decompression With Bone Marrow Aspirate Concentrate","has_exemption":false,"start_date":"2026-12-31","completion_date":"2035-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06412497","publication_url":"https://clinicaltrials.gov/study/NCT06412497","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","has_exemption":false,"start_date":"2024-06-05","completion_date":"2035-05-01","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06037356","publication_url":"https://clinicaltrials.gov/study/NCT06037356","title":"Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention","has_exemption":false,"start_date":"2025-01-01","completion_date":"2035-05-30","has_results":false,"results_due":false,"sponsor_name":"Queen Mary Hospital, Hong Kong","sponsor_slug":"queen-mary-hospital-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02800486","publication_url":"https://clinicaltrials.gov/study/NCT02800486","title":"Phase II Trial of Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory Glioblastoma Multiforme, Anaplastic Astrocytoma, and Anaplastic Oligoastrocytoma","has_exemption":false,"start_date":"2016-05-31","completion_date":"2035-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02177721","publication_url":"https://clinicaltrials.gov/study/NCT02177721","title":"A Field Study to Evaluate the Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario","has_exemption":false,"start_date":"2027-01-31","completion_date":"2035-05-31","has_results":false,"results_due":false,"sponsor_name":"Emergent BioSolutions","sponsor_slug":"emergent-biosolutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04731077","publication_url":"https://clinicaltrials.gov/study/NCT04731077","title":"Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)","has_exemption":false,"start_date":"2021-09-27","completion_date":"2035-06-01","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03167437","publication_url":"https://clinicaltrials.gov/study/NCT03167437","title":"An Open-Label, Proof of Concept Study of Vorinostat for the Treatment of Moderate-to-Severe Crohn's Disease, Ulcerative Colitis, and Chronic Granulomatous Disease Colitis Patients and Maintenance Therapy With Ustekinumab","has_exemption":false,"start_date":"2017-10-30","completion_date":"2035-06-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06422806","publication_url":"https://clinicaltrials.gov/study/NCT06422806","title":"A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas","has_exemption":false,"start_date":"2024-09-11","completion_date":"2035-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06728072","publication_url":"https://clinicaltrials.gov/study/NCT06728072","title":"Pilot Study Evaluating Microbiome Modulation Therapy (MBMT) With Ciprofloxacin, Metronidazole, and Aspirin in Addition to Standard of Care Chemotherapy in Patients Undergoing First-Line Therapy for Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-03-07","completion_date":"2035-07-01","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05535166","publication_url":"https://clinicaltrials.gov/study/NCT05535166","title":"SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma","has_exemption":false,"start_date":"2022-12-20","completion_date":"2035-07-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06711887","publication_url":"https://clinicaltrials.gov/study/NCT06711887","title":"An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension)","has_exemption":false,"start_date":"2025-05-19","completion_date":"2035-08-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06814145","publication_url":"https://clinicaltrials.gov/study/NCT06814145","title":"A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)","has_exemption":false,"start_date":"2025-04-16","completion_date":"2035-08-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01654133","publication_url":"https://clinicaltrials.gov/study/NCT01654133","title":"Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts","has_exemption":false,"start_date":"2012-07-31","completion_date":"2035-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07005024","publication_url":"https://clinicaltrials.gov/study/NCT07005024","title":"A Comparison of Anticoagulant Dosing Strategies to Reduce VTE and Mortality in Cancer Outpatients: A Randomized, Pragmatic Trial","has_exemption":false,"start_date":"2025-10-17","completion_date":"2035-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Vermont","sponsor_slug":"university-of-vermont","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06995053","publication_url":"https://clinicaltrials.gov/study/NCT06995053","title":"Image-Guidance With Triggered Beam Hold To Implanted Fiducial Markers or Hypersight for Stereotactic Body Radiotherapy for Prostate Cancer (ILLUSION)","has_exemption":false,"start_date":"2025-06-27","completion_date":"2035-09-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07072585","publication_url":"https://clinicaltrials.gov/study/NCT07072585","title":"A Phase 2/3 Randomized Trial Investigating Daratumumab on a Modified Augmented BFM (aBFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)","has_exemption":false,"start_date":"2026-08-28","completion_date":"2035-09-01","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07552181","publication_url":"https://clinicaltrials.gov/study/NCT07552181","title":"Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer","has_exemption":false,"start_date":"2026-09-30","completion_date":"2035-09-30","has_results":false,"results_due":false,"sponsor_name":"Yuan Yuan","sponsor_slug":"yuan-yuan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053436","publication_url":"https://clinicaltrials.gov/study/NCT07053436","title":"MMRC Horizon Two: A Phase II Randomized Adaptive Platform Trial Integrating Novel Therapies in High-Risk-Newly Diagnosed Multiple Myeloma (MMRC-100)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2035-10-01","has_results":false,"results_due":false,"sponsor_name":"Multiple Myeloma Research Consortium","sponsor_slug":"multiple-myeloma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220187","publication_url":"https://clinicaltrials.gov/study/NCT07220187","title":"A Randomized Phase III Study of Pirtobrutinib Plus R-CHOP vs. R-CHOP for Participants With Previously Untreated Richter Transformation (PIRAMID)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2035-10-01","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185165","publication_url":"https://clinicaltrials.gov/study/NCT07185165","title":"Eclipse: Flotufolastat F 18 to Determine Treatment Success Following Prostate Focal Therapy","has_exemption":false,"start_date":"2025-10-09","completion_date":"2035-10-25","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05128903","publication_url":"https://clinicaltrials.gov/study/NCT05128903","title":"Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study","has_exemption":false,"start_date":"2022-07-05","completion_date":"2035-10-26","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03841617","publication_url":"https://clinicaltrials.gov/study/NCT03841617","title":"The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer","has_exemption":false,"start_date":"2019-07-29","completion_date":"2035-11-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05828511","publication_url":"https://clinicaltrials.gov/study/NCT05828511","title":"Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma","has_exemption":false,"start_date":"2023-12-19","completion_date":"2035-11-02","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03371212","publication_url":"https://clinicaltrials.gov/study/NCT03371212","title":"A Prospective Randomized Trial of Modular Dual Mobility Acetabular Components Versus Conventional Single Bearing Components in Primary Total Hip Arthroplasty","has_exemption":false,"start_date":"2017-12-15","completion_date":"2035-12-01","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293585","publication_url":"https://clinicaltrials.gov/study/NCT07293585","title":"Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment","has_exemption":false,"start_date":"2025-12-16","completion_date":"2035-12-16","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701760","publication_url":"https://clinicaltrials.gov/study/NCT06701760","title":"Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)","has_exemption":false,"start_date":"2028-01-10","completion_date":"2035-12-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04699591","publication_url":"https://clinicaltrials.gov/study/NCT04699591","title":"Compassionate Use of Domperidone for Refractory Gastroparesis","has_exemption":false,"start_date":"2013-04-30","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Jose Cocjin","sponsor_slug":"jose-cocjin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02469662","publication_url":"https://clinicaltrials.gov/study/NCT02469662","title":"Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow","has_exemption":false,"start_date":"2015-06-30","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04042025","publication_url":"https://clinicaltrials.gov/study/NCT04042025","title":"A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101","has_exemption":false,"start_date":"2020-02-10","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Novartis Gene Therapies","sponsor_slug":"novartis-gene-therapies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06697301","publication_url":"https://clinicaltrials.gov/study/NCT06697301","title":"A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants With Advanced Melanoma (TeLuRide-006)","has_exemption":false,"start_date":"2025-05-22","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Eikon Therapeutics","sponsor_slug":"eikon-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06892522","publication_url":"https://clinicaltrials.gov/study/NCT06892522","title":"A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of T Cell Engaging Bi/Tri-specific Antibodies in Subjects With MM","has_exemption":false,"start_date":"2025-06-30","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282834","publication_url":"https://clinicaltrials.gov/study/NCT07282834","title":"Randomized Phase II Trial of Heated Vs. Pressurized/Aerosolized Chemotherapy (HIPEC vs. PIPAC) for Peritoneal Carcinomatosis","has_exemption":false,"start_date":"2026-01-05","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Patrick Wagner, MD, FACS","sponsor_slug":"patrick-wagner-md-facs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07186634","publication_url":"https://clinicaltrials.gov/study/NCT07186634","title":"Domain-Specific Appendix: OXYGEN","has_exemption":false,"start_date":"2026-04-06","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Monash University","sponsor_slug":"monash-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07365319","publication_url":"https://clinicaltrials.gov/study/NCT07365319","title":"A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008).","has_exemption":false,"start_date":"2026-06-15","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Eikon Therapeutics","sponsor_slug":"eikon-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447076","publication_url":"https://clinicaltrials.gov/study/NCT07447076","title":"A Platform Study of Novel Therapies for Children, Adolescents and Young Adults With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)","has_exemption":false,"start_date":"2026-06-17","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Sabine Mueller, MD, PhD","sponsor_slug":"sabine-mueller-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240649","publication_url":"https://clinicaltrials.gov/study/NCT07240649","title":"Emerging Indications for Hyperbaric Oxygen Treatment","has_exemption":false,"start_date":"2026-08-31","completion_date":"2035-12-31","has_results":false,"results_due":false,"sponsor_name":"Jay C. Buckey Jr.","sponsor_slug":"jay-c-buckey-jr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04074135","publication_url":"https://clinicaltrials.gov/study/NCT04074135","title":"Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2020-06-02","completion_date":"2036-01-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308886","publication_url":"https://clinicaltrials.gov/study/NCT07308886","title":"Phase II Study of Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-response (REGIMEN-KS HIV)","has_exemption":false,"start_date":"2026-04-08","completion_date":"2036-01-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02445222","publication_url":"https://clinicaltrials.gov/study/NCT02445222","title":"Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy","has_exemption":false,"start_date":"2015-11-02","completion_date":"2036-02-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07677839","publication_url":"https://clinicaltrials.gov/study/NCT07677839","title":"Redefining the Normal: Ultra-High Frequency Ultrasound Characterization of Lymphatic Anatomy in Patients With Breast Cancer","has_exemption":false,"start_date":"2026-06-17","completion_date":"2036-03-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05767047","publication_url":"https://clinicaltrials.gov/study/NCT05767047","title":"A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis","has_exemption":false,"start_date":"2023-03-23","completion_date":"2036-03-17","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07577414","publication_url":"https://clinicaltrials.gov/study/NCT07577414","title":"Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial","has_exemption":false,"start_date":"2026-06-17","completion_date":"2036-04-30","has_results":false,"results_due":false,"sponsor_name":"Dr Erin Perrone","sponsor_slug":"dr-erin-perrone","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02201992","publication_url":"https://clinicaltrials.gov/study/NCT02201992","title":"A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein","has_exemption":false,"start_date":"2015-03-23","completion_date":"2036-05-01","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03955445","publication_url":"https://clinicaltrials.gov/study/NCT03955445","title":"An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis","has_exemption":false,"start_date":"2019-10-03","completion_date":"2036-05-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918002","publication_url":"https://clinicaltrials.gov/study/NCT06918002","title":"A Phase 3, Open-label, Controlled, Randomized Study of Newly Diagnosed Multiple Myeloma Treatment, Designed to Evaluate the Efficacy and Safety of the Elranatamab-lenalidomide Combination as a Replacement for Chemotherapy Followed by Autologous Stem Cell Transplant in the Consolidation Phase, and to Compare Elranatamab With Standard of Care in the Maintenance Phase","has_exemption":false,"start_date":"2025-07-09","completion_date":"2036-05-31","has_results":false,"results_due":false,"sponsor_name":"Intergroupe Francophone du Myelome","sponsor_slug":"intergroupe-francophone-du-myelome","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07250477","publication_url":"https://clinicaltrials.gov/study/NCT07250477","title":"Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2026-01-30","completion_date":"2036-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07393373","publication_url":"https://clinicaltrials.gov/study/NCT07393373","title":"Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Hypochondroplasia: ACCEL OLE","has_exemption":false,"start_date":"2026-04-23","completion_date":"2036-05-31","has_results":false,"results_due":false,"sponsor_name":"QED Therapeutics, a BridgeBio company","sponsor_slug":"qed-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659379","publication_url":"https://clinicaltrials.gov/study/NCT07659379","title":"Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in Gotistobart Trials","has_exemption":false,"start_date":"2026-07-01","completion_date":"2036-07-01","has_results":false,"results_due":false,"sponsor_name":"OncoC4, Inc.","sponsor_slug":"oncoc4-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07671768","publication_url":"https://clinicaltrials.gov/study/NCT07671768","title":"ONE SHOT: Single-Fraction Adaptive MR-Guided Radiation Therapy for Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-07-01","completion_date":"2036-07-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05441813","publication_url":"https://clinicaltrials.gov/study/NCT05441813","title":"A Randomized, Open-label Study of Coconut Oil Mouth Rinse for Prophylaxis of Severe Oral Mucositis in Pediatric Patients Receiving Myeloablative Conditioning Regimens","has_exemption":false,"start_date":"2023-02-15","completion_date":"2036-07-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07708961","publication_url":"https://clinicaltrials.gov/study/NCT07708961","title":"Randomized Phase II Trial to Evaluate the Efficacy of WSD0922-FU When Combined With Adjuvant Temozolomide in Patients With EGFR Mutant Glioblastoma","has_exemption":false,"start_date":"2026-08-16","completion_date":"2036-07-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06342999","publication_url":"https://clinicaltrials.gov/study/NCT06342999","title":"Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome","has_exemption":false,"start_date":"2027-01-01","completion_date":"2036-07-31","has_results":false,"results_due":false,"sponsor_name":"Mauro H. Schenone","sponsor_slug":"mauro-h-schenone","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07654257","publication_url":"https://clinicaltrials.gov/study/NCT07654257","title":"Single FrAction Interstitial BreaSt BracHytherApy (SASHA)","has_exemption":false,"start_date":"2026-09-01","completion_date":"2036-09-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07667400","publication_url":"https://clinicaltrials.gov/study/NCT07667400","title":"Phase I/II Trial of Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer","has_exemption":false,"start_date":"2026-07-26","completion_date":"2036-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07420959","publication_url":"https://clinicaltrials.gov/study/NCT07420959","title":"Phase 1/2 Trial of ABBV-383 for Patients With Relapsed Refractory Waldenström Macroglobulinemia","has_exemption":false,"start_date":"2026-10-25","completion_date":"2036-10-25","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03435796","publication_url":"https://clinicaltrials.gov/study/NCT03435796","title":"Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells","has_exemption":false,"start_date":"2018-07-19","completion_date":"2036-11-30","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072482","publication_url":"https://clinicaltrials.gov/study/NCT06072482","title":"A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","has_exemption":false,"start_date":"2024-02-07","completion_date":"2036-12-31","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669846","publication_url":"https://clinicaltrials.gov/study/NCT05669846","title":"Phase II Feasibility Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","has_exemption":false,"start_date":"2025-01-08","completion_date":"2036-12-31","has_results":false,"results_due":false,"sponsor_name":"Diwakar Davar","sponsor_slug":"diwakar-davar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06974279","publication_url":"https://clinicaltrials.gov/study/NCT06974279","title":"Precision Neuromodulation in Post-Stroke Aphasia Using TMS","has_exemption":false,"start_date":"2025-09-01","completion_date":"2036-12-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932562","publication_url":"https://clinicaltrials.gov/study/NCT06932562","title":"A Randomized, Open-Label, Controlled Phase 3 Study of Comparing Daratumumab, Lenalidomide and Dexamethasone Induction Followed by Linvoseltamab Versus Continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients","has_exemption":false,"start_date":"2025-12-23","completion_date":"2036-12-31","has_results":false,"results_due":false,"sponsor_name":"European Myeloma Network B.V.","sponsor_slug":"european-myeloma-network-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548972","publication_url":"https://clinicaltrials.gov/study/NCT05548972","title":"Global, Multicenter and Prospective Post-Market Clinical Follow-Up Study of the G7® Dual Mobility Acetabular System With Vivacit-E® or Longevity® Poly Bearing & Instrumentation","has_exemption":false,"start_date":"2023-03-20","completion_date":"2037-01-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06938399","publication_url":"https://clinicaltrials.gov/study/NCT06938399","title":"Motiva Implants® Post-Approval Study (PAS) Protocol for Motiva SmoothSilk® Round Ergonomix® ('Ergonomix®') and SmoothSilk® Round ('Round') Breast Implants in Subjects Who Are Undergoing Primary Breast Augmentation, Revision Augmentation and Other Aesthetic Procedures","has_exemption":false,"start_date":"2025-05-01","completion_date":"2037-04-01","has_results":false,"results_due":false,"sponsor_name":"Motiva USA LLC","sponsor_slug":"motiva-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03935893","publication_url":"https://clinicaltrials.gov/study/NCT03935893","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers","has_exemption":false,"start_date":"2019-12-03","completion_date":"2037-06-30","has_results":false,"results_due":false,"sponsor_name":"Udai Kammula","sponsor_slug":"udai-kammula","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05201781","publication_url":"https://clinicaltrials.gov/study/NCT05201781","title":"Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel","has_exemption":false,"start_date":"2022-03-09","completion_date":"2037-07-29","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986382","publication_url":"https://clinicaltrials.gov/study/NCT06986382","title":"Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)","has_exemption":false,"start_date":"2025-07-31","completion_date":"2037-07-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05281809","publication_url":"https://clinicaltrials.gov/study/NCT05281809","title":"A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Antigen Receptor (CAR) T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2022-04-19","completion_date":"2037-08-05","has_results":false,"results_due":false,"sponsor_name":"John Lister","sponsor_slug":"john-lister","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214532","publication_url":"https://clinicaltrials.gov/study/NCT07214532","title":"SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer","has_exemption":false,"start_date":"2026-03-24","completion_date":"2037-11-15","has_results":false,"results_due":false,"sponsor_name":"Natera, Inc.","sponsor_slug":"natera-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191744","publication_url":"https://clinicaltrials.gov/study/NCT06191744","title":"A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)","has_exemption":false,"start_date":"2024-02-05","completion_date":"2037-11-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06661720","publication_url":"https://clinicaltrials.gov/study/NCT06661720","title":"Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE","has_exemption":false,"start_date":"2025-03-14","completion_date":"2037-11-30","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116473","publication_url":"https://clinicaltrials.gov/study/NCT07116473","title":"A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients With Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)","has_exemption":false,"start_date":"2025-11-30","completion_date":"2037-11-30","has_results":false,"results_due":false,"sponsor_name":"Eidos Therapeutics, a BridgeBio company","sponsor_slug":"eidos-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07637513","publication_url":"https://clinicaltrials.gov/study/NCT07637513","title":"Phase III Trial of Consolidation Tarlatamab + Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer (LS-SCLC)","has_exemption":false,"start_date":"2027-01-31","completion_date":"2037-11-30","has_results":false,"results_due":false,"sponsor_name":"PrECOG, LLC.","sponsor_slug":"precog-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06651281","publication_url":"https://clinicaltrials.gov/study/NCT06651281","title":"A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis","has_exemption":false,"start_date":"2024-11-25","completion_date":"2037-12-17","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05587244","publication_url":"https://clinicaltrials.gov/study/NCT05587244","title":"Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners","has_exemption":false,"start_date":"2023-05-08","completion_date":"2037-12-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01770418","publication_url":"https://clinicaltrials.gov/study/NCT01770418","title":"A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2013-03-31","completion_date":"2038-01-31","has_results":false,"results_due":false,"sponsor_name":"Proton Collaborative Group","sponsor_slug":"proton-collaborative-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04192591","publication_url":"https://clinicaltrials.gov/study/NCT04192591","title":"A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)","has_exemption":false,"start_date":"2020-01-30","completion_date":"2038-02-28","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03989947","publication_url":"https://clinicaltrials.gov/study/NCT03989947","title":"A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia","has_exemption":false,"start_date":"2019-06-12","completion_date":"2038-05-31","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03538899","publication_url":"https://clinicaltrials.gov/study/NCT03538899","title":"Phase I/II Safety and Efficacy Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) in Newly Diagnosed Patients Using Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells","has_exemption":false,"start_date":"2018-05-31","completion_date":"2038-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976763","publication_url":"https://clinicaltrials.gov/study/NCT05976763","title":"A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy With Zanubrutinib as Upfront Treatment in Older Patients With Mantle Cell Lymphoma","has_exemption":false,"start_date":"2023-10-20","completion_date":"2038-08-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00912041","publication_url":"https://clinicaltrials.gov/study/NCT00912041","title":"BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia","has_exemption":false,"start_date":"2009-05-31","completion_date":"2038-09-30","has_results":false,"results_due":false,"sponsor_name":"Leigh R. Hochberg, MD, PhD.","sponsor_slug":"leigh-r-hochberg-md-phd","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04081701","publication_url":"https://clinicaltrials.gov/study/NCT04081701","title":"68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.","has_exemption":false,"start_date":"2019-09-04","completion_date":"2038-12-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05929807","publication_url":"https://clinicaltrials.gov/study/NCT05929807","title":"A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents With Achondroplasia","has_exemption":false,"start_date":"2023-06-21","completion_date":"2039-01-31","has_results":false,"results_due":false,"sponsor_name":"Ascendis Pharma Growth Disorders A/S","sponsor_slug":"ascendis-pharma-growth-disorders-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226388","publication_url":"https://clinicaltrials.gov/study/NCT07226388","title":"Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: The Impact of Modern Implant Options","has_exemption":false,"start_date":"2026-02-03","completion_date":"2039-02-28","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06582745","publication_url":"https://clinicaltrials.gov/study/NCT06582745","title":"Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib","has_exemption":false,"start_date":"2024-06-24","completion_date":"2039-06-30","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06498635","publication_url":"https://clinicaltrials.gov/study/NCT06498635","title":"Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT)","has_exemption":false,"start_date":"2025-04-01","completion_date":"2039-07-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06652633","publication_url":"https://clinicaltrials.gov/study/NCT06652633","title":"A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies","has_exemption":false,"start_date":"2024-09-09","completion_date":"2039-07-31","has_results":false,"results_due":false,"sponsor_name":"Lakefront Biotherapeutics NV","sponsor_slug":"lakefront-biotherapeutics-nv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598371","publication_url":"https://clinicaltrials.gov/study/NCT06598371","title":"A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors","has_exemption":false,"start_date":"2024-11-21","completion_date":"2039-08-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04208529","publication_url":"https://clinicaltrials.gov/study/NCT04208529","title":"A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)","has_exemption":false,"start_date":"2021-01-20","completion_date":"2039-09-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431827","publication_url":"https://clinicaltrials.gov/study/NCT07431827","title":"A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)","has_exemption":false,"start_date":"2026-03-18","completion_date":"2039-10-26","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02598349","publication_url":"https://clinicaltrials.gov/study/NCT02598349","title":"A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2016-04-30","completion_date":"2039-10-31","has_results":false,"results_due":false,"sponsor_name":"Proton Collaborative Group","sponsor_slug":"proton-collaborative-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06617286","publication_url":"https://clinicaltrials.gov/study/NCT06617286","title":"MAC-CAR: A Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults With Poor-Risk Classical Hodgkin Lymphoma (cHL)","has_exemption":false,"start_date":"2026-12-01","completion_date":"2039-12-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03007589","publication_url":"https://clinicaltrials.gov/study/NCT03007589","title":"Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics","has_exemption":false,"start_date":"2014-04-30","completion_date":"2040-01-31","has_results":false,"results_due":false,"sponsor_name":"Sun Protection Foundation","sponsor_slug":"sun-protection-foundation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05568719","publication_url":"https://clinicaltrials.gov/study/NCT05568719","title":"A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY","has_exemption":false,"start_date":"2022-12-28","completion_date":"2040-02-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849480","publication_url":"https://clinicaltrials.gov/study/NCT05849480","title":"A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)","has_exemption":false,"start_date":"2024-05-08","completion_date":"2040-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05620771","publication_url":"https://clinicaltrials.gov/study/NCT05620771","title":"Phase II Study Therasphere® (Yttrium-90) in Combination With Systemic Therapy in Patients With High-risk Hepatocellular Carcinoma","has_exemption":false,"start_date":"2022-11-30","completion_date":"2040-07-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02689440","publication_url":"https://clinicaltrials.gov/study/NCT02689440","title":"Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study","has_exemption":false,"start_date":"2016-02-19","completion_date":"2040-12-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07073014","publication_url":"https://clinicaltrials.gov/study/NCT07073014","title":"A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia","has_exemption":false,"start_date":"2025-06-20","completion_date":"2040-12-31","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02760849","publication_url":"https://clinicaltrials.gov/study/NCT02760849","title":"WISP (Women Choosing Surgical Prevention)","has_exemption":false,"start_date":"2016-05-02","completion_date":"2041-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07095452","publication_url":"https://clinicaltrials.gov/study/NCT07095452","title":"Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","has_exemption":false,"start_date":"2026-01-08","completion_date":"2042-01-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05962346","publication_url":"https://clinicaltrials.gov/study/NCT05962346","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia","has_exemption":false,"start_date":"2026-12-31","completion_date":"2043-07-31","has_results":false,"results_due":false,"sponsor_name":"Mauro H. Schenone","sponsor_slug":"mauro-h-schenone","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03486873","publication_url":"https://clinicaltrials.gov/study/NCT03486873","title":"A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab","has_exemption":false,"start_date":"2018-08-21","completion_date":"2043-08-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281730","publication_url":"https://clinicaltrials.gov/study/NCT06281730","title":"Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy","has_exemption":false,"start_date":"2024-03-23","completion_date":"2044-02-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358638","publication_url":"https://clinicaltrials.gov/study/NCT06358638","title":"Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY","has_exemption":false,"start_date":"2024-04-03","completion_date":"2044-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's National Research Institute","sponsor_slug":"childrens-national-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01538056","publication_url":"https://clinicaltrials.gov/study/NCT01538056","title":"Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study","has_exemption":false,"start_date":"2011-03-31","completion_date":"2045-01-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02917460","publication_url":"https://clinicaltrials.gov/study/NCT02917460","title":"Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data","has_exemption":false,"start_date":"2016-07-31","completion_date":"2050-12-31","has_results":false,"results_due":false,"sponsor_name":"Rady Pediatric Genomics & Systems Medicine Institute","sponsor_slug":"rady-pediatric-genomics-systems-medicine-institute","status":"ongoing","is_pact":true,"days_late":null}]}